These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 1617334)

  • 41. New therapeutic approaches in autoimmune rheumatic diseases, with special emphasis on rheumatoid arthritis.
    Kalden JR; Manger B
    Br J Rheumatol; 1995 Mar; 34(3):193-6. PubMed ID: 7728390
    [No Abstract]   [Full Text] [Related]  

  • 42. Low-Dose IL-2 Therapy in Autoimmune and Rheumatic Diseases.
    Graßhoff H; Comdühr S; Monne LR; Müller A; Lamprecht P; Riemekasten G; Humrich JY
    Front Immunol; 2021; 12():648408. PubMed ID: 33868284
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biological therapies directed against cells in autoimmune disease.
    Hasler P
    Springer Semin Immunopathol; 2006 Jun; 27(4):443-56. PubMed ID: 16738955
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Advances and failures in rheumatology during the past 3 decades].
    Châtel A
    Orv Hetil; 1976 Oct; 117(40):2427-9. PubMed ID: 787885
    [No Abstract]   [Full Text] [Related]  

  • 45. [Targeted immunotherapy against interleukin 2 receptors (IL-2R)--an attempt at synthesis].
    Sabliński T; Wasik MA; Tilney NL; Kupiec-Wegliński JW
    Postepy Hig Med Dosw; 1992; 46(3):275-85. PubMed ID: 1293580
    [No Abstract]   [Full Text] [Related]  

  • 46. T cell receptor peptide vaccines as immunotherapy.
    Brostoff SW
    Agents Actions Suppl; 1995; 47():53-8. PubMed ID: 7785503
    [No Abstract]   [Full Text] [Related]  

  • 47. Immunological evaluation of cytokine and anticytokine immunotherapy in vivo: what have we learnt?
    Jorgensen C; Apparailly F; Sany J
    Ann Rheum Dis; 1999 Mar; 58(3):136-41. PubMed ID: 10364909
    [No Abstract]   [Full Text] [Related]  

  • 48. Mechanisms of autoimmunity in human diseases: a critical review of current dogma.
    Benson RA; Brewer JM; Platt AM
    Curr Opin Rheumatol; 2014 Mar; 26(2):197-203. PubMed ID: 24445477
    [TBL] [Abstract][Full Text] [Related]  

  • 49. T-cell receptor peptide vaccination in the treatment of rheumatoid arthritis.
    Bridges SL; Moreland LW
    Rheum Dis Clin North Am; 1998 Aug; 24(3):641-50. PubMed ID: 9710892
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Advances in the treatment of autoimmune diseases; cellular activity, type-1/type-2 cytokine secretion patterns and their modulation by therapeutic peptides.
    Mouzaki A; Deraos S; Chatzantoni K
    Curr Med Chem; 2005; 12(13):1537-50. PubMed ID: 15974986
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunomodulators.
    Schrieber L
    Agents Actions Suppl; 1988; 24():254-64. PubMed ID: 3055878
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for the immunotherapy of rheumatological diseases.
    Waldmann T
    Arthritis Res; 2002; 4 Suppl 3(Suppl 3):S161-7. PubMed ID: 12110135
    [TBL] [Abstract][Full Text] [Related]  

  • 53. B cells as a therapeutic target in autoimmune disease.
    Goronzy JJ; Weyand CM
    Arthritis Res Ther; 2003; 5(3):131-5. PubMed ID: 12723978
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical and preclinical studies presented at the Keystone Symposium on Arthritis, Related Diseases, and Cytokines.
    Ralph P
    Lymphokine Cytokine Res; 1993 Aug; 12(4):261-3. PubMed ID: 8218599
    [TBL] [Abstract][Full Text] [Related]  

  • 55. T-cell receptors and rheumatic disease: approaches to repertoire analysis.
    Bowness P; Bell J
    Br J Rheumatol; 1992 Jan; 31(1):3-8. PubMed ID: 1730102
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exosomes as nanocarriers for immunotherapy of cancer and inflammatory diseases.
    Tran TH; Mattheolabakis G; Aldawsari H; Amiji M
    Clin Immunol; 2015 Sep; 160(1):46-58. PubMed ID: 25842185
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New approaches for antirheumatic therapy.
    Kirkham B; Panayi GS
    Baillieres Clin Rheumatol; 1990 Dec; 4(3):649-61. PubMed ID: 2093444
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Translational aspects on the role of B-cells in autoimmune diseases. "From bench to bedside" and "from bed to benchside"].
    Mei H; Dörner T
    Z Rheumatol; 2009 Jul; 68(5):364-9. PubMed ID: 19513730
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel, non-antigen-specific therapeutic approaches to autoimmune/inflammatory diseases.
    Illei GG; Lipsky PE
    Curr Opin Immunol; 2000 Dec; 12(6):712-8. PubMed ID: 11102777
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CD4-targeted immune intervention: a strategy for the therapy of AIDS and autoimmune disease.
    Auffray C; Piatier-Tonneau D; Kroemer G
    Trends Biotechnol; 1991 Apr; 9(4):124-31. PubMed ID: 1367392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.